Recurrent thrombotic thrombocytopenic purpura in a young boy with systemic lupus erythematosus

Journal of Clinical Rheumatology

Volumn 13, Issue 4, 2007, Pages 224-228

  Yuen, Lai Kei ^a   Lai, Wai Ming ^a   Tong, Pak Chiu ^a   Poon, Wing Tat ^a   Tse, Kei Chiu ^a   Chiu, Man Chun ^a  

^a PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

Plasmapheresis; Systemic lupus erythematosus; Thrombotic thrombocytopenic purpura

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAMIPRIL; SERUM ALBUMIN;

ARTICLE; BLOOD SMEAR; CASE REPORT; CHILD; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; HYPERTENSION; KIDNEY BIOPSY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLASMAPHERESIS; PRIORITY JOURNAL; PROPHYLAXIS; PROTEINURIA; RECURRENT DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; ULTRASOUND;

CHILD; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METHYLPREDNISOLONE; PLASMAPHERESIS; PULSE THERAPY, DRUG; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECURRENCE;

EID: 34548421505     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e318133a476     Document Type: Article

References (24)

1. George JN, Sadler JE, Lammle B. Platelets: thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2002;315-334.
2. Veyradier A, Meyer D. Thrombotic thrombocytopenic purpura and its diagnosis. J Thromb Haemost. 2005;3:2420-2424.
3. Yarranton H, Machin SJ. An update on the pathogenesis and management of acquired thrombotic thrombocytopenic purpura. Curr Opin Neurol. 2003;16:367-373.
4. Brunner HI, Freedman M, Silverman ED. Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis Rheum. 1999;42:2346-2355.
5. Sakarcan A, Stallworth J. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case and review. Pediatr Nephrol. 2001;16:672-674.
6. Bray VJ, West SG, Kristo DA. Simultaneous presentation of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. South Med J. 1994;87:827-830.
7. Hess DC, Sethi K, Awad E. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus and antiphospholipid antibodies: effective treatment with plasma exchange and immunosuppression. J Rheumatol. 1992;19:1417.
8. Caramaschi P, Riccetti MM, Pasini AF, et al. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura. Report of three cases and review of the literature. Lupus. 1998;7:37-41.
9. Perez-Sanchez I, Angita J, Pintado T. Use of cyclophosphamide in the treatment of thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus: report of two cases. Ann Hematol. 1999;78:285-287.
10. Chak WK, Lam DSY, Lo WH, et al. Thrombotic thrombocytopenic purpura as a rare complication in childhood systemic lupus erythematosus: case report and literature review. Hong Kong Med J. 2003;9:363-368.
11. Jonsson OG, Fink CW. Systemic lupus erythematosus presenting as thrombotic thrombocytopenic purpura. J Rheumatol. 1990;17:973-974.
12. Mying SJ, Yoo B, Lee KH, et al. A case of systemic lupus erythematosus developing two years after remission of thrombotic thrombocytopenic purpura. Korean J Intern Med. 1996;11:178-182.
13. Gatenby PA, Smith H, Kirwan P, et al. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura. A case report and review of relationship. J Rheumatol. 1981;8:504-508.
14. Oen K, Petty RE, Schroeder ML, et al. Thrombotic thrombocytopenic purpura in a girl with systemic lupus erythematosus. J Rheumatol. 1980;7:727-729.
15. Vasoo S, Thumboo J, Fong KY. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: disease activity and the use of cytotoxic drugs. Lupus. 2002;11:443-450.
16. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35:630-640.
17. Lammle B, Kremer Hovinga JA, Alberio L. Thrombotic thrombocytopenic purpura. J Thromb Haemost. 2005;3:1663-1675.
18. Studt JD, Kremer JA, Alberio L, et al. Von Willebrand factor-cleaving protease(ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory. Swiss Med Wkly. 2003;133:325-332.
19. Coppo P, Wolf M, Veyradier A, et al. Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura. Br J Haematol. 2005;132:66-74.
20. Zheng XL, Kaufman RM, Goodnough, et al. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood. 103:4043-4049.
21. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpuraCanadian Apheresis Study Group. N Engl J Med. 1991;325:393-397.
22. Bohm M, Betz C, Miesbach W, et al. The course of ADAMTS13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine. Br J Haematol. 2005;129:644-652.
23. Ziman A, Mitri M, Klapper E, et al. Combination vincristine and plasma exchange as initial therapy in patents with thrombotic thrombocytopenic purpura: one institution's experience and review of the literature. Transfusion. 2005;45:41-49.
24. Fakhouri F, Vernant JP, Veyradier A, et al. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13 deficient thrombotic thrombocytopenic purpura: a study of 11 cases. Blood. 2005;106:1932-1937.